Chemomab Therapeutics (CMMB) Reports In-Line Q1 EPS

Chemomab Therapeutics (NASDAQ: CMMB) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day